National Academies Press: OpenBook

Vaccine Safety Research, Data Access, and Public Trust (2005)

Chapter: Appendix D Meeting One—Agenda

« Previous: Appendix C Acronyms
Suggested Citation:"Appendix D Meeting One—Agenda." Institute of Medicine. 2005. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC: The National Academies Press. doi: 10.17226/11234.
×

Appendix D
Meeting One—Agenda

The National Academies

Institute of Medicine

Committee on Review of NIP’s Research Procedures and Data Sharing Program

Meeting One

AGENDA

Speakers and Times Subject to Change

Monday, August 23, 2004

10:30 a.m. – 5:45 p.m.

Meeting Location:

Keck Center of the National Academies

Room 100

500 Fifth Street, NW

Washington, DC 20001

10:00–10:30 a.m.

Registration and Coffee

Suggested Citation:"Appendix D Meeting One—Agenda." Institute of Medicine. 2005. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC: The National Academies Press. doi: 10.17226/11234.
×

10:30–10:45 a.m.

Welcome, Introductions, and Opening Statement

 

John Bailar, MD, PhD

Committee Chair

10:45–10:55 a.m.

Description of the Vaccine Safety Datalink (VSD)

 

Robert Davis, MD, MPH

Visiting Scientist

Office of Genomics and Disease Prevention

Centers for Disease Control and Prevention

10:55–11:15 a.m.

Background on the NCHS Research Data Center (RDC)

 

Jennifer Madans, PhD

Associate Director for Science

National Center for Health Statistics

Centers for Disease Control and Prevention

11:15–11:40 a.m.

Description of the VSD Data Sharing Program

 

Melinda Wharton, MD, MPH

Acting Deputy Director

National Immunization Program

Centers for Disease Control and Prevention

11:40–11:45 a.m.

Future Plans for the VSD Data Sharing Program

 

Jennifer Madans, PhD

11:45 a.m. – 12:05 p.m.

Questions from the Committee

12:05–12:15 p.m.

Charge to the Committee

 

Roger Bernier, PhD, MPH

Senior Advisor For Scientific Strategy and Innovation

National Immunization Program

Centers for Disease Control and Prevention

12:15–12:30 p.m.

Questions from the Committee

12:30–1:15 p.m.

Lunch (Cafeteria on 3rd Floor)

Suggested Citation:"Appendix D Meeting One—Agenda." Institute of Medicine. 2005. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC: The National Academies Press. doi: 10.17226/11234.
×

1:15–1:45 p.m.

Researchers’ Experience with the VSD Data Sharing Program

 

Mark R. Geier, MD, PhD

President

The Genetic Centers of America

 

David Geier

President

MedCon

1:45–2:15 p.m.

Questions from the Committee

2:15–2:25 p.m.

RDC Monitor’s Experience with the VSD Data Sharing Program

 

Peter Shabe, MS

Director of Data Management and Statistics

TrialTech

2:25–2:40 p.m.

NIP’s Experience with the VSD Data Sharing Program

 

Roger Bernier, PhD, MPH

2:40–3:00 p.m.

Questions from the Committee

3:00–3:10 p.m.

Break

3:10–3:30 p.m.

Perspective and Experience of a Managed Care Organization Involved in the VSD Data Sharing Program

 

Richard Platt, MD, MSc

Professor and Chair

Department of Ambulatory Care and Prevention

Harvard Medical School

Harvard Pilgrim Health Care

3:30–3:45 p.m.

Questions from the Committee

3:45–4:05 p.m.

Access to California Health Interview Survey Data through the UCLA Data Access Center

 

Lee Habte, MA

Data Access Center Manager

UCLA Center for Health Policy Research

Suggested Citation:"Appendix D Meeting One—Agenda." Institute of Medicine. 2005. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC: The National Academies Press. doi: 10.17226/11234.
×

4:05–4:20 p.m.

Questions from the Committee

4:20–4:40 p.m.

Perspective of a Consumer Group on Access to VSD Data

 

Barbara Loe Fisher

President

National Vaccine Information Center

4:40–4:55 p.m.

Questions from the Committee

4:55–5:40 p.m.

Public Comment

 

(A sign-up sheet will be available at the registration table)

5:40–5:45 p.m.

Closing Remarks

 

John Bailar, MD, PhD

Committee Chair

Suggested Citation:"Appendix D Meeting One—Agenda." Institute of Medicine. 2005. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC: The National Academies Press. doi: 10.17226/11234.
×
Page 119
Suggested Citation:"Appendix D Meeting One—Agenda." Institute of Medicine. 2005. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC: The National Academies Press. doi: 10.17226/11234.
×
Page 120
Suggested Citation:"Appendix D Meeting One—Agenda." Institute of Medicine. 2005. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC: The National Academies Press. doi: 10.17226/11234.
×
Page 121
Suggested Citation:"Appendix D Meeting One—Agenda." Institute of Medicine. 2005. Vaccine Safety Research, Data Access, and Public Trust. Washington, DC: The National Academies Press. doi: 10.17226/11234.
×
Page 122
Next: Appendix E Meeting Two—Agenda »
Vaccine Safety Research, Data Access, and Public Trust Get This Book
×
Buy Paperback | $48.00 Buy Ebook | $38.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The Vaccine Safety Datalink (VSD) is a large, linked database of patient information that was developed jointly by CDC and several private managed care organizations in 1991. It includes data on vaccination histories, health outcomes, and characteristics of more than 7 million patients of eight participating health organizations. Researchers from CDC and the managed care groups have used VSD information to study whether health problems are associated with vaccinations. The subsequent VSD data sharing program was launched in 2002 to allow independent, external researchers access to information in the database.

In this report, the committee that was asked to review aspects of this program recommends that two new oversight groups are needed to ensure that the policies and procedures of the VSD and its data sharing program are implemented as fairly and openly as possible.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!